Parallax Volatility Advisers, L.P. Heron Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $114,999 - $314,500	-50,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $231,500 - $497,000	50,000 New	50,000 $286,000
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $423,250 - $655,500	-25,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $578,750 - $708,500	25,000 New	25,000 $611,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $5.79 Million - $7.88 Million	-193,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $5.1 Million - $8.11 Million	193,000 New	193,000 $7.5 Million

175

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $201M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.